Medicine
Cefotan 1 g/10 mL powder for injection
Cefotan 1 g/10 mL powder for injection is a prescription medicine containing Cefotetan for intramuscular, intravenous use, marketed by PAI Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
The vials should be stored at 20°C to 25° C (68° to 77° F) and should be…
Key facts
- Active ingredient (INN)
- Cefotetan
- Brand
- Cefotan
- Strength
- 1 g/10 mL
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials
- Marketing authorisation holder
- PAI Pharma
- Manufacturer
- PAI Pharma
- Origin register
- US FDA, United States
- Storage
- The vials should be stored at 20°C to 25° C (68° to 77° F) and should be protected from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DC05 Cefotetan
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 April 2024
- Identifiers
- RxCUI 1722919, 1722921, 1731542 +1DailyMed set ID f1510f5e-d001-44e0-accb-27cf79fd4f9aNDC 0121-0976, 0121-0977Application NDA050588
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 tray / 10 mL in 1 vial | 0121-0976-10 | PAI Pharma | 8 April 2024 |
| 10 vial in 1 tray / 20 mL in 1 vial | 0121-0977-10 | PAI Pharma | 8 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 December 1985 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cefotetan 1 g/10 mL powder for injection.
Other strengths and forms of Cefotetan
Clinical summary
Cefotetan is a cephalosporin antibacterial indicated for the therapeutic treatment of infections when caused by susceptible strains of the designated organisms. It is available as powder for injection for intramuscular and intravenous use. MedsAcross supplies Cefotetan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefotetanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefotan prescribing information (PAI Pharma) · U.S. National Library of Medicine, DailyMed
Need Cefotan 1 g/10 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.